Variant report
Variant | esv3422104 |
---|---|
Chromosome Location | chr3:162307483-162310231 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:162307801..162310469-chr3:162314134..162316904,3 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571212612 | chr3:162307499-162307500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs533504213 | chr3:162307570-162307571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs7426960 | chr3:162307619-162307620 | Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs146189730 | chr3:162307654-162307655 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535991873 | chr3:162307701-162307702 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs138967146 | chr3:162307717-162307718 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs565788846 | chr3:162307753-162307754 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs576597207 | chr3:162307759-162307760 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548313264 | chr3:162307786-162307787 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191650432 | chr3:162307814-162307815 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs76820134 | chr3:162307817-162307818 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs75005014 | chr3:162307837-162307838 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs115548661 | chr3:162307848-162307849 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541410322 | chr3:162307877-162307878 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs561297561 | chr3:162307909-162307910 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370843443 | chr3:162307921-162307922 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530196925 | chr3:162307934-162307935 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs75441702 | chr3:162307941-162307942 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs143815907 | chr3:162307993-162307994 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs75351074 | chr3:162308071-162308072 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs537724817 | chr3:162308095-162308096 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs112526774 | chr3:162308106-162308107 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs368459801 | chr3:162308111-162308112 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs564802640 | chr3:162308141-162308142 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs183533667 | chr3:162308169-162308170 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187248847 | chr3:162308200-162308201 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs191137303 | chr3:162308219-162308220 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs372482494 | chr3:162308233-162308234 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567182688 | chr3:162308261-162308262 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182279377 | chr3:162308270-162308271 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs34813025 | chr3:162308276-162308277 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549655468 | chr3:162308294-162308295 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186940158 | chr3:162308297-162308298 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs556458165 | chr3:162308301-162308302 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs140531383 | chr3:162308311-162308312 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191453515 | chr3:162308332-162308333 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183073943 | chr3:162308351-162308352 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368640597 | chr3:162308384-162308385 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs188064659 | chr3:162308399-162308400 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs554939810 | chr3:162308442-162308443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs35423336 | chr3:162308446-162308447 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs374135915 | chr3:162308455-162308456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs201599501 | chr3:162308463-162308464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs374984088 | chr3:162308464-162308465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs199922714 | chr3:162308465-162308466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs538505752 | chr3:162308475-162308476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs35798209 | chr3:162308489-162308490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs66495029 | chr3:162308497-162308498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs376466957 | chr3:162308507-162308508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs34108938 | chr3:162308510-162308511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:162305800-162307600 | Weak transcription | Dnd41 | blood |
2 | chr3:162307600-162308400 | Genic enhancers | Dnd41 | blood |
3 | chr3:162308400-162308800 | Weak transcription | Dnd41 | blood |
4 | chr3:162308800-162310400 | Enhancers | Dnd41 | blood |